Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hep & Pancreatic Ca

Cancer
Nadine Abi-Jaoudeh
Pilot Trial Comparing Circulating Tumor DNA (ctDNA) From Immediate Draining Vein vs. Standard Peripheral Vein Sample in Patients Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
Liver
Other Digestive Organ
Pancreas

Study Description

This is a, prospective single center pilot study to investigate whether ctDNA detection can be improved by sampling the cancer draining vein vs. a peripheral vein (current practice). As a secondary endpoint, both ctDNA results will be compared with percutaneous biopsy (standard of care).

Eligibility

You can participate in this study if you

  • Are 18 years of age or older
  • Have or are undergoing work-up for hepatobiliary and/or pancreatic cancer
  • Are scheduled for an image-guided percutaneous or trans-jugular biopsy of a lesion

You cannot participate in this study if you

  • Have a gross body weight over 375 pounds
  • Have moderate to severe ascites (abdominal swelling caused by accumulation of fluid)

and unable to undergo trans-jugular biopsy or sufficient drainage

  • Cannot have a peripheral blood draw for ctDNA
A female nurse attentively holds a tablet, ready to assist with patient care and medical information.

Interested in Participating in this Trial?

Thank you for your interest with our team.

One of our specialists will be in contact with you soon.